Global Bovine Serum Albumin Market – Industry Trends and Forecast to 2029

Bovine Serum Albumin Market Analysis and Size

The market for bovine serum albumin is expected to experience significant growth opportunities in the coming years. This rising market growth is due to the introduction of a novel product in the field of bovine serum albumin. Furthermore, increasing this serum as a dietary whey protein is boosting market growth opportunities.

Data Bridge Market Research analyses that the bovine serum albumin market which was valued at USD 5.58 billion in 2021 is expected to reach the value of USD 18.42 billion by 2029, at a CAGR of 16.1% during the forecast period of 2022-2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team includes in-depth expert analysis, import/export analysis, pricing analysis, production consumption analysis, patent analysis and consumer behaviour.

Bovine Serum Albumin Market Scope and Segmentation

Market Definition

Albumin is a globular protein that is water soluble and found in blood plasma. It is produced in the liver and is required for blood volume maintenance as well as the transport of enzyme, hormone, and bile salt molecules. It is frequently available in human, bovine, and recombinant forms. They are critical for maintaining intravascular colloid osmotic pressure (COP) and preventing fluid leakage into the tissue.

Bovine Serum Albumin Market Dynamics

Drivers

• Prevalence of chronic diseases around the world

The increasing prevalence of chronic medical ailments around the world is one of the key factors driving market growth. Albumin is commonly used to treat hypovolemia, acute respiratory distress syndrome (ARDS), nephrosis, renal dialysis, liver failure, cardiopulmonary disorders, and hypoalbuminemia. Furthermore, the growing geriatric population, which is more vulnerable to such illnesses, is driving market growth.

• High preference from industry scientist due to its various beneficial characteristics

As a protein standard, various research organisations use bovine serum albumin. It has been used to determine unknown quantities of other proteins while keeping the quantities of bovine serum albumin in mind. Furthermore, bovine serum albumin has no discernible effect on various biochemical reactions. This factor encourages many industry scientists to choose this serum. Other notable characteristics that are expected to boost opportunities in the bovine serum albumin market include high water solubility and high purity.

Opportunity

In contrast, the market is expected to benefit from the development of cost-effective therapeutics through large-scale production and high market potential in untapped emerging economies. People are more aware of their health nowadays, which compels them to maintain their health and increases demand for albumin for drug development. This has prompted many key players to expand into emerging markets, creating a lucrative growth opportunity in the albumin market.

Restraints

However, adverse reactions and a growing shift toward serum-free solutions may impede albumin market growth. The use of albumin substitutes in replacement therapies and other applications may limit the albumin market's growth.

This bovine serum albumin market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the bovine serum albumin market contact Data Bridge Market Research for an Analyst Brief, our saffron will help you take an informed market decision to achieve market growth.

COVID-19 Impact on Bovine Serum Albumin Market

The sudden outbreak of COVID-19 cases has had a negative impact on the development, production, and supply of reagents and consumables. Furthermore, various companies in the bovine serum albumin market have suffered negative effects from the pandemic in the last year. The coronavirus has caused the closure of industrial establishments due to the imposition of lockdown to maintain social distance. Other than essential commodities, the pandemic disrupted other industrial establishments.

Recent Development

• Paclitaxel protein-bound particles for injection (albumin-bound), a generic version of Abraxane, was launched in the United States by Apotex Corp. in April 2022.
• Bio Products Laboratory (BPL) announced in January 2022 that the National Medical Products Administration (NMPA) of China had granted a licence to market ALBUMINEX 25% product in China.

Global Bovine Serum Albumin Market Scope

The bovine serum albumin market is segmented on the basis of product and application. The growth amongst these segments will help you analyse meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product

• Human Serum Albumin
• Bovine Albumin
• Recombinant Serum Albumin

Application

• Therapeutic
• Drug Delivery
• Culture Media
• Vaccine Ingredient
• Others

Bovine Serum Albumin Market Regional Analysis/Insights

The bovine serum albumin market is analysed and market size insights and trends are provided by country, product and application as referenced above.

The countries covered in the bovine serum albumin market report are U.S., Canada and Mexico in North America, Germany, Sweden, Poland, Denmark, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

Asia-Pacific is expected to hold the largest percent share of the global market for bovine serum albumin during the forecast period. The major factors driving the growth of the albumin market in Asia-Pacific are an increase in the use of albumin for disease treatment, the presence of a large patient pool, and an increased focus on enhanced diagnosis.

Market regulation that impact the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Competitive Landscape and Bovine Serum Albumin Market Share Analysis

The bovine serum albumin market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to bovine serum albumin market.

Some of the major players operating in the bovine serum albumin market are:

• Thermo Fisher Scientific (U.S.)
• Bio-Rad Laboratories, Inc (U.S.)
• Merck KGAA (Germany)
• Itoham Yonekyu Holdings Inc (Japan)
• Proliant Biologicals (U.S.)
• Kraeber & Co Gmbh (Germany)
• Rockland Immunochemicals Inc (U.S.)
• Rocky mountain biologicals (U.S.)
• BelHealth investment partners, LLC (U.S.)
• Bio-Techne Corporation (U.S.)
• Prospec-Tany Technogene Ltd (Israel)
• LGC Group (U.K.)
• Promega Corporation (U.S.)
• Biological Industries (Israel)
• Serion GmbH (Germany)

SKU-54665